:BCMA

Jiaqi Xu1,2,3, Yan Wang1,2,3, Ni Yuan4

  • 1State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.

mAbs
|September 18, 2025
PubMed
概括

本研究分析了纳米体 (Nb) 技术和专利,揭示了创新趋势和潜在的候选药物. 它为Nb药物开发和专利策略提供了见解,使用B细胞成熟抗原 (BCMA) 作为案例研究.